Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. (Q45995404)
Jump to navigation
Jump to search
scientific article published on 7 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. |
scientific article published on 7 October 2011 |
Statements
1 reference
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. (English)
1 reference
1 reference
1 reference
Annamaria Colao
1 reference
Angela Falbo
1 reference
Laura Carrillo
1 reference
Maria Teresa Villani
1 reference
Francesco Orio
1 reference
Tiziana Russo
1 reference
Annalisa Di Cello
1 reference
Fulvio Cappiello
1 reference
Sabina Capasso
1 reference
Achille Tolino
1 reference
Pasquale Mastrantonio
1 reference
Ettore Cittadini
1 reference
METformin in High Responder Italian Group
1 reference
7 October 2011
1 reference
1 reference
96
1 reference
1384-1390.e4
1 reference
6
1 reference
Identifiers
1 reference
1 reference